Last update 08 May 2025

Cilazapril/Hydrochlorothiazide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Inhibace Plus, Inibace Plus
Target
ACE x NCC
Action
inhibitors
Mechanism
ACE inhibitors(Angiotensin-converting enzyme inhibitors), NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors)
Therapeutic Areas
Cardiovascular Diseases
Active Indication
Hypertension
Inactive Indication-
Originator Organization
F. Hoffmann-La Roche Ltd.
Active Organization
F. Hoffmann-La Roche Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
Italy (01 Jan 1997),
Hypertension
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC22H33N3O6
InChIKeyJQRZBPFGBRIWSN-YOTVLOEGSA-N
CAS Registry92077-78-6
View All Structures (2)

Related

100 Clinical Results associated with Cilazapril/Hydrochlorothiazide
Login to view more data
100 Translational Medicine associated with Cilazapril/Hydrochlorothiazide
Login to view more data
100 Patents (Medical) associated with Cilazapril/Hydrochlorothiazide
Login to view more data
1
Literatures (Medical) associated with Cilazapril/Hydrochlorothiazide
01 Jun 1999Journal of Pharmaceutical and Biomedical AnalysisQ3 · MEDICINE
Determination of active ingredients in the pharmaceutical formulations containing hydrochlorothiazide and its binary mixtures with benazepril hydrochloride, triamterene and cilazapril by ratio spectra derivative spectrophotometry and vierordt’s method
Q3 · MEDICINE
100 Deals associated with Cilazapril/Hydrochlorothiazide
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
C09BA08
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypertension
Italy
F. Hoffmann-La Roche Ltd.
01 Jan 1997
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free